Substance / Medication

Levocetirizine dihydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Development of medicated chewing gum of taste masked levocetirizine dihydrochloride using different gum bases:andevaluation.
Marzouk Maha A, Darwish Manal K, Abd El-Fattah Marwa A · Drug Dev Ind Pharm · 2020
PMID: 31996053Observational
Urticarial reaction to the antihistamine levocetirizine dihydrochloride.
Kränke Birger, Mayr-Kanhäuser Sigrid · Dermatology · 2005
PMID: 15785059Case Report
Nano-Spray-Dried Levocetirizine Dihydrochloride with Mucoadhesive Carriers and Cyclodextrins for Nasal Administration.
Mirankó Mirella, Tóth Judit, Bartos Csilla et al. · Pharmaceutics · 2023
PMID: 36839640OtherFull text (PMC)
Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Levocetirizine Dihydrochloride.
Charoo Naseem A, Abdallah Daud B, Ahmed Daoud T et al. · J Pharm Sci · 2023
PMID: 36581104Other
Volumetric and conductivity studies of the interaction between levocetirizine dihydrochloride and the amino acids l-alanine and l-glutamine in aqueous solutions.
Zolkiflee Nur Farahani, Meor Mohd Affandi Meor Mohd Redzuan, Abdul Majeed Abu Bakar · Heliyon · 2023
PMID: 37009243OtherFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Levocetirizine dihydrochloride (substance)
SNOMED CT
425461004
UMLS CUI
C1321643

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.